期刊文献+

抗氧化低密度脂蛋白抗体与冠心病的关系 被引量:7

Autoanitibodies against oxidatively modified low-density-lipoprotein are associated with coronary heart disease
原文传递
导出
摘要 目的 :探讨氧化修饰低密度脂蛋白 (ox LDL)引发的免疫反应在动脉粥样硬化 (AS)发生发展中的作用 ,揭示ox LDL致AS的免疫学机制。方法 :90例冠心病 (CHD)患者 (分为 3组 :稳定型心绞痛组、不稳定型心绞痛组、急性心肌梗死组 ) ,采用ELISA法检测其血液中ox LDL、ox LDL Ab及ox LDL IC水平。并入选 4 0例健康人群作为对照组。结果 :CHD各组血液中ox LDL、ox LDL Ab及ox LDL IC水平明显高于对照组 ,以急性心肌梗死组为最高。 3项指标的阳性率以ox LDL IC为最高。ox LDL Ab与血清脂蛋白无关 ,与ox LDL呈负相关 ,与ox LDL IC正相关。结论 :ox LDL的免疫反应参与AS的发生发展 。 Objective:To study the immunopathogenesis of ox LDL on the development of atheriosclerosis.Methods:Ninety patients with CHD(3 groups: SA, UA, AMI) were involved in this study and the levels of ox LDL, anti-ox LDL antibodies(ox LDL Ab) and ox LDL containing immune complexes(ox LDL IC) in circulation were determined by ELISA.Results:The levels of ox LDL?ox LDL Ab and ox LDL IC in blood from patients with CHD were significantly higher than those of controls,and the levels of group AMI were the highest.ox LDL Ab was not correlated with serum TG, HDL and LDL. There were negative correlation between the levels of ox LDL Ab and ox LDL,and positive correlation between the levels of ox LDL Ab and ox LDL IC.Conclusion:Oxidative modification of LDL could elicit humoral immune response,the autoantibodies and immune complexes were associated with the presence or progression of arteriosclerosis,it was an inflammatory disease including a series of highly complex humoral?cellular and molecular responses.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2003年第10期588-590,593,共4页 Journal of Clinical Cardiology
关键词 氧化低密度脂蛋白 免疫反应 自身抗体 动脉粥样硬化 Oxidatively modified low density lipoprotein Immune response Autoantibody Atherosclerosis
  • 相关文献

参考文献10

  • 1陈雪云,马兴义,刘传民,田庆印.冠心病患者血浆氧化修饰低密度脂蛋白与血清一氧化氮的变化及相关性研究[J].临床心血管病杂志,1999,15(2):72-73. 被引量:13
  • 2Witztum J L, Steinberg D. Roie of oxidized low density lipoprotein in atherogenesis. J Clin Invest, 1991,88:1785-1792.
  • 3Steinberg D, Parthasarathy S, Carew T E, et al. Beyond cholesterol: Modifications of low-density lipoprorein that increase its atherogenicity. N Eng J Med,1989,320: 915-923.
  • 4BouUier A, Hamon M, Walters-Laporte E, et al. Detection of autoantibodies against oxidized low density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease. Clin Chim Acta, 1995,238:1-10.
  • 5Witztum J L, Palinski W. Are immunological mechanisms relevant for the development of atherosclerosis? Clin Immunoh 1999,90 : 153 - 156.
  • 6Parums D V, Brown D L, Mitchinsin M J. Serum antibodies to oxidized low-density lipoprotein and ceroid in chonic periaortitis. Arch Pathol Lab Med, 1990, 114: 383-387.
  • 7Bui M N, Sack M N, Moutsatsos G, et al. Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis. Am Heart J, 1996, 131 :663-667.
  • 8Cornacoff J B, Hebert L A, Smead W L, et al. Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest, 1983,71 :236-247.
  • 9Lougheed M, Zhang H F, Steinbrecher U P. Oxidizedlow density lipoprotein is resistant to cathepsins and accumulates within macrophages. J Bio Chem, 1991,266: 14519-14525.
  • 10Lopes-Virella M F, Virella G. Cytokines, modified lipoproteins and arteriosclerosis in diabetes. Diabetes, 1996,45(Suppl 3) :S40-S44.

二级参考文献3

  • 1王华梁 陈思聪 等.双抗夹心法检测血浆氧化修饰低密度脂蛋白[J].上海医学检验杂志,1994,9:135-139.
  • 2Bui M N,Am Heart J,1996年,131卷,663页
  • 3王华粱,上海医学检验杂志,1994年,9卷,135页

共引文献12

同被引文献61

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部